Guangyong Zhang
Papers
1
Total Citations
4
H-Index
1
About
Guangyong Zhang is a leading clinical researcher in gastrointestinal oncology, with a focused expertise in optimizing surgical outcomes for gastric cancer patients. His work centers on the intersection of neoadjuvant chemotherapy, minimally invasive surgery, and perioperative care. Zhang’s major contribution lies in pioneering evidence-based protocols to enhance recovery and reduce complications in high-risk surgical populations. His most cited study, a multicenter randomized controlled trial protocol (GISSG2023-01), investigates the effect of perioperative probiotic supplements on short-term clinical outcomes after laparoscopic or robotic radical gastrectomy following neoadjuvant chemotherapy. This work addresses a critical gap in managing advanced gastric cancer patients, who often face compromised gut health and immune function after chemotherapy. By designing a rigorous trial to evaluate probiotics as a supportive intervention, Zhang aims to mitigate postoperative complications and improve recovery trajectories. With 4 citations for this protocol alone, his research is gaining traction among surgical oncologists and nutrition specialists. Zhang’s dedication to refining multimodal treatment strategies underscores his impact on advancing personalized, evidence-based care for gastric cancer patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1